Prevalence and molecular characterization of human T cell leukemia virus type 2 in a group of intravenous drug users coinfected with HIV type 1 in Portugal

AIDS Research and Human Retroviruses

Volumn 21, Issue 4, 2005, Pages 249-255

  Silva, Ana Filipa ^a   Almeida, Catarina ^a   Martins, Helena Cortes ^a   Coutinho, Rodrigo ^b   Leitão, Emília ^b   Silva, Rui ^b   Paixão, Maria Teresa ^a   Pádua, Elizabeth ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b Plano Integrado Prevencao Das T   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG USE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PORTUGAL; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SEROLOGY; SPAIN; VIRUS CHARACTERIZATION; VIRUS IDENTIFICATION;

BASE SEQUENCE; EPIDEMIOLOGY, MOLECULAR; FEMALE; HIV INFECTIONS; HIV-1; HTLV-I ANTIBODIES; HTLV-II ANTIBODIES; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; PORTUGAL; RNA, VIRAL; SEQUENCE ALIGNMENT; SUBSTANCE ABUSE, INTRAVENOUS; TERMINAL REPEAT SEQUENCES;

EID: 18244367120     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.249     Document Type: Article

References (29)

1. Wang H, Norris KM, and Mansky LM: Analysis of bovine leukemia virus Gag membrane targeting and late domain function. J Virol 2002;76:8485-8493.
2. Bangham CRM: The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J Gen Virol 2003;84:3177-3189.
3. Hall WW, Isaac R, Zhu SW, et al.: Human T lymphotropic virus type II (HTLV-II): Epidemology, molecular properties, and clinical features of infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:S204-S214.
4. Heneide W: The phylogeny and molecular epidemiology of human T-cell lymphotropic virus type II. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:S236-S241.
5. Switzer WM, Pieniazek D, Swanson P, et al.: Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J Virol 1995;69:621-632.
6. Fujiyoshi T, Li HC, Yashiki S, et al.: Characteristic distribution of HTLV type I and HTLV type II carriers among native ethnic groups in South America. AIDS Res Hum Retroviruses 1999;15:1235-1239.
7. Gessain A, Mauclére P, Froment A, et al.: Isolation and molecular characterization of a human T-cell lymphotropic virus type II (HTLV-II), subtype B, from a healthy pygmy living in a remote area of Cameroon: An ancient origin for HTLV-II in Africa. Proc Natl Acad Sci USA 1995;92:4041-4045.
8. Vandamme A-M, Salemi M, Brussel MV, et al.: African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies. J Virol 1998;72:4327-4340.
9. Taylor GP: The epidemiology and clinical impact of HTLV infections in Europe. AIDS Rev 1999;1:195-204.
10. Soriano V, Calderón E, Esparza B, et al.: HTLV-I/II infections in Spain. Int J Epidemiol 1993;22:716-719.
11. Henrard DR, Soriano V, Robertson E, et al.: Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and -2 assay. J Clin Microbiol 1995;33:1735-1738.
12. Zella D, Mori L, Sala M, et al.: HTLV-II infection in Italian drug abusers. Lancet 1990;336:575-576.
13. Varnier OF, Lillo F, Alexander SS, et al.: HTLV seroreactivity in Italian intravenous drug addicts is primarily due to HTLV-II infections. JAMA 1991;265:597.
14. HTLV European Research Network: Seroepidemiology of the human T-cell leukemia/lymphoma viruses in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:68-77.
15. Guimarães ML, Bastos FI, Telles PR, et al.: Retrovirus infections in a sample of injecting drug users in Rio de Janeiro city, Brazil: Prevalence of HIV-1 subtypes, and co-infection with HTLV-1/II. J Clin Virol 2001;21:143-151.
16. Hall WW, Takahashi H, Liu C, et al.: Multiple isolates and characteristics of human T-cell leukemia virus type II. J Virol 1992;66:2456-2463.
17. Dube DK, Sherman MP, Saksena NK, et al.: Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II. J Virol 1993;67:1175-1184.
18. Vallejo A and Garcia-Saiz A: Isolation and nucleotide sequence analysis of human T-cell lymphotropic virus type II in Spain. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:517-519.
19. Zella D, Cavicchi A, Salemi M, et al.: Molecular characterization of two isolates of human T cell leukaemia virus type II from Italian drug abusers and comparison of genome structure with other isolates. J Gen Virol 1993;74:437-444.
20. Covas DT and Kashima S: Complete nucleotide sequence of the genomes of two Brazilian specimens of human T-lymphotropic virus type 2 (HTLV-2). AIDS Res Hum Retroviruses 2003;19:689-697.
21. Pádua E, Neves R, Sobral R, et al.: Seroprevalence study of HTLV infection in a group of IVDUs infected with HIV. AIDS Res Hum Retroviruses 2001;17:S40.
22. Kwok S, Ehrlich G, Poiesz B, et al.: Enzymatic amplification of HTLV-I viral sequences from peripheral blood mononuclear cells and infected tissues. Blood 1988;72:1117-1123.
23. Vallejo A, Ferrante P, Soriano V, et al.: Nucleotide sequence and restriction fragment-length polymorphism analysis of human T-cell lymphotropic virus type II (HTLV-II) in southern Europe: Evidence for the HTLV-IIa and HTLV-IIb subtypes. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:384-391.
24. 23a. Thompson JD, Higgins DG, and Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
25. 23b. Saitou N and Nei M: The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 1987;4:406-425.
26. Shimotohno K, Takahashi Y, Shimizu N, et al.: Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: An open reading frame for the protease gene. Proc Natl Acad Sci USA 1985;82:3101-3105.
27. Lee H, Idler KB, Swanson P, et al.: Complete nucleotide sequence of HTLV-II isolate NRA: Comparison of envelope sequence variation of HTLV-II isolates from U.S. blood donors and U.S. and Italian IV drug users. Virology 1993;196:57-69.
28. Eiraku N, Monken C, Kubo T, et al.: Nucleotide sequence and restriction fragment length polymorphism analysis of the long terminal repeat of human T cell leukemia virus type II. AIDS Res Hum Retroviruses 1995;11:625-636.
29. Böni J, Bisset LR, Burckhardt JJ, et al.: Prevalence of human T-cell leukemia virus types I and II in Switzerland. J Med Virol 2004;72:328-337.